According to a recent LinkedIn post from Harvey, an interview with Elisabeth Cappuyns highlights how law firm DLA Piper approached generative AI adoption using Harvey’s platform. The post describes a phased strategy centered on targeted training, clearly defined use cases, and frequent engagement through demos and “GenAI open houses.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that tailoring training by practice area and seniority, combined with peer-led advocacy, helped move usage from isolated early adopters to broader organizational uptake. It indicates that GenAI use now spans multiple practices, regions, and seniority levels, touching disputes, transactions, and pro bono work.
For investors, this case study style content may point to Harvey’s traction within large, complex professional-services clients, where successful deployment can translate into sticky, multi-practice usage. Broad-based adoption at a global firm like DLA Piper could imply higher usage-based revenue potential, lower churn risk, and a stronger reference case for winning additional law firm and enterprise customers.
The emphasis on structured change management around GenAI may also signal Harvey’s intent to position itself not only as a technology provider but as a partner in adoption strategy. If replicated across other clients, this approach could enhance Harvey’s competitive positioning in the legal tech and enterprise AI markets, supporting pricing power and cross-sell opportunities over time.